These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9697721)

  • 61. CGP 53437, an orally bioavailable inhibitor of human immunodeficiency virus type 1 protease with potent antiviral activity.
    Alteri E; Bold G; Cozens R; Faessler A; Klimkait T; Lang M; Lazdins J; Poncioni B; Roesel JL; Schneider P
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2087-92. PubMed ID: 8257128
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1).
    Yamaguchi K; Honda M; Ikigai H; Hara Y; Shimamura T
    Antiviral Res; 2002 Jan; 53(1):19-34. PubMed ID: 11684313
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inhibition of HIV-1 replication by a peptide dimerization inhibitor of HIV-1 protease.
    Davis DA; Brown CA; Singer KE; Wang V; Kaufman J; Stahl SJ; Wingfield P; Maeda K; Harada S; Yoshimura K; Kosalaraksa P; Mitsuya H; Yarchoan R
    Antiviral Res; 2006 Nov; 72(2):89-99. PubMed ID: 16687179
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Human immunodeficiency virus type 1 (HIV-1) inhibitory interactions between protease inhibitor Ro 31-8959 and zidovudine, 2',3'-dideoxycytidine, or recombinant interferon-alpha A against zidovudine-sensitive or -resistant HIV-1 in vitro.
    Johnson VA; Merrill DP; Chou TC; Hirsch MS
    J Infect Dis; 1992 Nov; 166(5):1143-6. PubMed ID: 1328402
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Rapid phenotypic drug susceptibility assay for HIV-1 with a CCR5 expressing indicator cell line.
    Pirounaki M; Heyden NA; Arens M; Ratner L
    J Virol Methods; 2000 Mar; 85(1-2):151-61. PubMed ID: 10716348
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inhibitory effects of triterpene-azidothymidine conjugates on proliferation of human immunodeficiency virus type 1 and its protease.
    Ma CM; Nakamura N; Hattori M; Kawahata T; Otake T
    Chem Pharm Bull (Tokyo); 2002 Jun; 50(6):877-80. PubMed ID: 12045355
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Complementary antiviral efficacy of hydroxyurea and protease inhibitors in human immunodeficiency virus-infected dendritic cells and lymphocytes.
    Piccinini G; Foli A; Comolli G; Lisziewicz J; Lori F
    J Virol; 2002 Mar; 76(5):2274-8. PubMed ID: 11836405
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Repurposing Saquinavir for Host-Directed Therapy to Control Mycobacterium Tuberculosis Infection.
    Pires D; Valente S; Calado M; Mandal M; Azevedo-Pereira JM; Anes E
    Front Immunol; 2021; 12():647728. PubMed ID: 33841429
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effect of increasing alpha1-acid glycoprotein concentration on the antiviral efficacy of human immunodeficiency virus protease inhibitors.
    Zhang XQ; Schooley RT; Gerber JG
    J Infect Dis; 1999 Dec; 180(6):1833-7. PubMed ID: 10558938
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Therapeutic strategies towards HIV-1 infection in macrophages.
    Perno CF; Svicher V; Schols D; Pollicita M; Balzarini J; Aquaro S
    Antiviral Res; 2006 Sep; 71(2-3):293-300. PubMed ID: 16806514
    [TBL] [Abstract][Full Text] [Related]  

  • 71. L-chicoric acid, an inhibitor of human immunodeficiency virus type 1 (HIV-1) integrase, improves on the in vitro anti-HIV-1 effect of Zidovudine plus a protease inhibitor (AG1350).
    Robinson WE
    Antiviral Res; 1998 Aug; 39(2):101-11. PubMed ID: 9806487
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Differential inhibition of cytochrome P450 3A4, 3A5 and 3A7 by five human immunodeficiency virus (HIV) protease inhibitors in vitro.
    Granfors MT; Wang JS; Kajosaari LI; Laitila J; Neuvonen PJ; Backman JT
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):79-85. PubMed ID: 16433896
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Substance P modulates human immunodeficiency virus replication in human peripheral blood monocyte-derived macrophages.
    Ho WZ; Cnaan A; Li YH; Zhao H; Lee HR; Song L; Douglas SD
    AIDS Res Hum Retroviruses; 1996 Feb; 12(3):195-8. PubMed ID: 8835196
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficacy of Tat-conjugated ritonavir-loaded nanoparticles in reducing HIV-1 replication in monocyte-derived macrophages and cytocompatibility with macrophages and human neurons.
    Borgmann K; Rao KS; Labhasetwar V; Ghorpade A
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):853-62. PubMed ID: 21175357
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Constitutive production of nonenveloped human immunodeficiency virus type 1 particles by a mammalian cell line and effects of a protease inhibitor on particle maturation.
    Babé LM; Craik CS
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2430-9. PubMed ID: 7840583
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long-term effects of HIV-1 protease inhibitors on insulin secretion and insulin signaling in INS-1 beta cells.
    Schütt M; Zhou J; Meier M; Klein HH
    J Endocrinol; 2004 Dec; 183(3):445-54. PubMed ID: 15590971
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Anti-human immunodeficiency virus type 1 activities of U-90152 and U-75875 in human brain cell cultures.
    Peterson PK; Gekker G; Hu S; Chao CC
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2465-8. PubMed ID: 7530933
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In vitro inhibition of the replication of human immunodeficiency virus type 1 by beta-mercaptoethylamine (cysteamine).
    Bergamini A; Ventura L; Mancino G; Capozzi M; Placido R; Salanitro A; Cappannoli L; Faggioli E; Stoler A; Rocchi G
    J Infect Dis; 1996 Jul; 174(1):214-8. PubMed ID: 8655998
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antiviral properties of palinavir, a potent inhibitor of the human immunodeficiency virus type 1 protease.
    Lamarre D; Croteau G; Wardrop E; Bourgon L; Thibeault D; Clouette C; Vaillancourt M; Cohen E; Pargellis C; Yoakim C; Anderson PC
    Antimicrob Agents Chemother; 1997 May; 41(5):965-71. PubMed ID: 9145853
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antiviral efficacy of the novel compound BIT225 against HIV-1 release from human macrophages.
    Khoury G; Ewart G; Luscombe C; Miller M; Wilkinson J
    Antimicrob Agents Chemother; 2010 Feb; 54(2):835-45. PubMed ID: 19995924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.